Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

July 17, 2024 by Alan Khadavi

Viaskin Milk Patch for Milk Allergy

A milk patch is being developed for IgE mediated cow’s milk allergy. We have spoken about patch treatment previously regarding peanut allergy.

Viaskin Peanut Patch Safety Results

Peanut Patch (Viaskin) for peanut allergy

Cow’s milk allergy affects approximately 2-3% of infants worldwide, often presenting with symptoms ranging from mild to severe anaphylaxis. The primary treatment strategy has been strict avoidance of cow’s milk proteins and the use of epinephrine for severe reactions. However, recent advancements in immunotherapy have introduced the Viaskin patch as a promising alternative for inducing tolerance in CMA patients.

So far the peanut patch has not come to market, but there have been 2 treatments FDA approved for food allergy. Palforzia for peanut allergy and Xolair for food allergies in general.

Palforzia (formerly AR101) and peanut allergy

Xolair for Food Allergy

The Viaskin patch utilizes epicutaneous immunotherapy (EPIT), where allergens are delivered to the immune system through intact skin. The patch contains cow’s milk proteins and is applied to the skin, allowing for gradual exposure to the allergen. This method aims to modulate the immune response, promoting tolerance through the activation of regulatory T cells and reduction of IgE-mediated allergic reactions.

No approved treatment exists for cow milk allergy currently.  A study was published in JAMA Pediatrics, this was a phase 1/2 randomized trial assessing the safety and efficacy of different doses in children with cow’s milk allergy. The Viaskin patch delivers small amounts of cow’s milk protein daily via a patch directly applied to the skin. After 12 months of treatment  the highest response rate was observed in the 300 microgram dose (as opposed to the 150 and 500).

The Viaskin milk patch has shown promise in increasing the threshold of reactivity, thereby reducing the risk of accidental reactions and improving the quality of life for CMA patients.

The Viaskin milk patch has been generally well-tolerated in clinical trials. The most common adverse events reported were local skin reactions at the site of application, including erythema and pruritus. These reactions were typically mild to moderate and resolved spontaneously. No severe systemic allergic reactions were attributed to the Viaskin patch, highlighting its safety as an immunotherapy option for CMA.

The Viaskin Cow Milk Patch offers a novel and effective approach to desensitizing children with cow’s milk allergy. By gradually introducing cow’s milk proteins through the skin, the Viaskin patch has the potential to improve tolerance and reduce the risk of severe allergic reactions. Continued research and clinical trials will be crucial in further understanding its long-term benefits and establishing its place in the management of cow’s milk allergy.

Cow’s milk oral immunotherapy is also an option as well, studies have shown that it has a strong long term adherence. This could be because dairy products are in numerous attractive food items (chocolate, ice cream, pizza).

 

Filed Under: Blog, Food allergy

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page